900181851	900181851	CD	B-NP	O
|	|	NN	I-NP	O
OMMC	OMMC	NN	I-NP	O
|	|	NN	I-NP	O
05179465	05179465	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
8721738	8721738	CD	B-NP	O
|	|	CC	I-NP	O
6/21/2006	6/21/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
acute	acute	JJ	I-NP	O
on	on	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
4/12/2006	4/12/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
7/22/2006	7/22/2006	CD	B-NP	O
******	******	SYM	I-NP	O
FINAL	FINAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NN	I-NP	O
******	******	SYM	B-VP	O
HACKBARTH	HACKBARTH	NN	B-NP	O
,	,	,	O	O
CLAIR	CLAIR	NN	B-NP	B-protein
E	E	NNP	B-NP	O
522-03-89-2	522-03-89-2	CD	I-NP	O
Call	Call	NNP	I-NP	O
Ba	Ba	NNP	I-NP	O
Sa	Sa	NNP	I-NP	O
La	La	NNP	I-NP	O
No	No	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
CAR	CAR	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
PATIENT	PATIENT	NN	I-NP	O
ON	ON	NN	I-NP	O
:	:	:	O	O
1/8/06	1/8/06	CD	B-NP	O
AT	AT	NN	I-NP	O
04	04	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NN	I-NP	O
CONTINGENT	CONTINGENT	NN	I-NP	O
UPON	UPON	NN	I-NP	O
Attending	Attend	VBG	B-VP	O
evaluation	evaluation	NN	B-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
VANNULAND	VANNULAND	NNP	B-NP	O
,	,	,	O	O
LYLE	LYLE	NNP	B-NP	O
KEVIN	KEVIN	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
CPR	CPR	NN	I-NP	B-protein
,	,	,	O	O
No	No	DT	B-NP	O
defib	defib	NN	I-NP	O
,	,	,	O	O
No	No	DT	B-NP	O
intubation	intubation	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
services	service	NNS	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ACETYLSALICYLIC	ACETYLSALICYLIC	NN	B-NP	O
ACID	ACID	NN	I-NP	O
325	325	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
9/16/06	9/16/06	CD	B-NP	O
by	by	IN	B-PP	O
PAPICH	PAPICH	NNP	B-NP	O
,	,	,	O	O
LUCIEN	LUCIEN	NNP	B-NP	O
L	L	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
895231165	895231165	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
md	md	NN	B-NP	O
aware	aware	JJ	I-NP	O
ALLOPURINOL	ALLOPURINOL	NN	I-NP	O
100	100	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
9/16/06	9/16/06	CD	B-NP	O
by	by	IN	B-PP	O
MESSANA	MESSANA	NN	B-NP	O
,	,	,	O	O
HOYT	HOYT	NNP	B-NP	O
J	J	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
895231165	895231165	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ALLOPURINOL	ALLOPURINOL	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
md	md	NN	B-NP	B-protein
aware	aware	JJ	I-NP	I-protein
COLACE	COLACE	NN	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
DOCUSATE	DOCUSATE	NNP	I-NP	I-protein
SODIUM	SODIUM	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
100	100	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
BID	BID	NNP	I-NP	I-protein
NEXIUM	NEXIUM	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
ESOMEPRAZOLE	ESOMEPRAZOLE	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
20	20	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
DAILY	DAILY	NNP	I-NP	I-protein
FERROUS	FERROUS	NNP	I-NP	I-protein
SULFATE	SULFATE	NNP	I-NP	I-protein
325	325	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
BID	BID	NNP	I-NP	I-protein
Food/Drug	Food/Drug	NNP	I-NP	I-protein
Interaction	Interaction	NNP	I-NP	I-protein
Instruction	Instruction	NNP	I-NP	I-protein
Avoid	Avoid	NNP	I-NP	I-protein
milk	milk	NN	I-NP	I-protein
and	and	CC	I-NP	O
antacid	antacid	NN	I-NP	B-protein
GLIPIZIDE	GLIPIZIDE	NN	I-NP	I-protein
5	5	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
BID	BID	NN	I-NP	I-protein
ISOSORBIDE	ISOSORBIDE	NN	I-NP	I-protein
DINITRATE	DINITRATE	NN	I-NP	I-protein
5	5	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
TID	TID	NN	I-NP	I-protein
LEVOXYL	LEVOXYL	NN	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
LEVOTHYROXINE	LEVOTHYROXINE	NNP	I-NP	I-protein
SODIUM	SODIUM	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
100	100	CD	I-NP	I-protein
MCG	MCG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
DAILY	DAILY	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
9/16/06	9/16/06	CD	B-NP	O
by	by	IN	B-PP	O
KABRICK	KABRICK	NNP	B-NP	O
,	,	,	O	O
FLETCHER	FLETCHER	NNP	B-NP	O
E	E	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
895231165	895231165	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LEVOTHYROXINE	LEVOTHYROXINE	NNP	B-NP	O
SODIUM	SODIUM	NNP	I-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
md	md	NN	B-NP	O
aware	aware	JJ	I-NP	O
ATIVAN	ATIVAN	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
LORAZEPAM	LORAZEPAM	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
0.5	0.5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Anxiety	Anxiety	NNP	I-NP	O
TOPROL	TOPROL	NNP	I-NP	O
XL	XL	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
METOPROLOL	METOPROLOL	NNP	I-NP	O
SUCCINATE	SUCCINATE	NNP	I-NP	O
EXTENDED	EXTENDED	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
100	100	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

PRAVASTATIN	PRAVASTATIN	NN	B-NP	B-protein
40	40	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
BEDTIME	BEDTIME	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
grapefruit	grapefruit	NN	I-NP	O
unless	unless	IN	B-SBAR	O
MD	MD	NN	B-NP	O
instructs	instruct	NNS	I-NP	O
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

Override	Override	NNP	B-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
9/16/06	9/16/06	CD	B-NP	O
by	by	IN	B-PP	O
BEEDHAM	BEEDHAM	NNP	B-NP	O
,	,	,	O	O
FAUSTINO	FAUSTINO	NNP	B-NP	O
N	N	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
895231165	895231165	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
PRAVASTATIN	PRAVASTATIN	NN	B-NP	O
SODIUM	SODIUM	NNP	I-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
md	md	NN	B-NP	O
aware	aware	JJ	I-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
9/16/06	9/16/06	CD	B-NP	O
by	by	IN	B-PP	O
BUFFONE	BUFFONE	NNP	B-NP	O
,	,	,	O	O
BORIS	BORIS	NNP	B-NP	O
M	M	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
NIACIN	NIACIN	NN	B-NP	B-protein
,	,	,	O	O
VIT	VIT	NN	B-NP	B-protein
.	.	.	O	O

B-3	B-3	NN	B-NP	B-protein
&	&	CC	I-NP	O
PRAVASTATIN	PRAVASTATIN	NN	I-NP	O
SODIUM	SODIUM	NN	I-NP	O
Reason	Reason	NN	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
nd	nd	NN	B-NP	B-protein
aware	aware	JJ	I-NP	I-protein
MULTIVITAMIN	MULTIVITAMIN	NN	I-NP	I-protein
THERAPEUTIC	THERAPEUTIC	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
THERAPEUTIC	THERAPEUTIC	NN	I-NP	I-protein
MULTIVI	MULTIVI	NN	I-NP	I-protein
...	...	:	O	I-protein
-RRB-	-RRB-	SYM	B-NP	I-protein
1	1	CD	I-NP	I-protein
TAB	TAB	NN	I-NP	I-protein
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
9/16/06	9/16/06	CD	B-NP	O
by	by	IN	B-PP	O
DALZIEL	DALZIEL	NNP	B-NP	O
,	,	,	O	O
CRUZ	CRUZ	NNP	B-NP	O
J	J	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
PRAVASTATIN	PRAVASTATIN	NN	B-NP	B-protein
PO	PO	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
ref	ref	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
011084372	011084372	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
NIACIN	NIACIN	NN	B-NP	B-protein
,	,	,	O	O
VIT	VIT	NN	B-NP	B-protein
.	.	.	O	O

B-3	B-3	NN	B-NP	B-protein
&	&	CC	I-NP	O
PRAVASTATIN	PRAVASTATIN	NN	I-NP	O
SODIUM	SODIUM	NN	I-NP	O
Reason	Reason	NN	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
nd	nd	NN	B-NP	O
aware	aware	JJ	I-NP	O
TORSEMIDE	TORSEMIDE	NN	I-NP	O
40	40	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
9/21	9/21	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
COUMADIN	COUMADIN	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
1	1	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QPM	QPM	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
ROUTINE	ROUTINE	NNP	I-NP	O
,	,	,	O	O
20	20	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Standard	Standard	NNP	I-NP	O
Admin	Admin	NNP	I-NP	O
Time	Time	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
No	No	NNP	I-NP	O
high	high	JJ	I-NP	O
Vitamin-K	Vitamin-K	NN	I-NP	O
containing	contain	VBG	B-VP	O
foods	food	NNS	B-NP	O
Alert	Alert	NNP	B-NP	O
overridden	overridden	JJ	B-ADJP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
9/16/06	9/16/06	CD	B-NP	O
by	by	IN	B-PP	O
POSTLETHWAITE	POSTLETHWAITE	NNP	B-NP	O
,	,	,	O	O
ROSENDO	ROSENDO	NNP	B-NP	O
A	A	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LEVOTHYROXINE	LEVOTHYROXINE	NNP	B-NP	O
SODIUM	SODIUM	NNP	I-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ALLOPURINOL	ALLOPURINOL	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
PRAVASTATIN	PRAVASTATIN	NN	B-NP	O
SODIUM	SODIUM	NNP	I-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
md	md	NN	B-NP	O
aware	aware	JJ	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
Patient	Patient	NN	B-NP	O
should	should	MD	B-VP	O
measure	measure	VB	I-VP	O
weight	weight	NN	B-NP	O
daily	daily	JJ	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
Fluid	Fluid	NN	B-NP	O
restriction	restriction	NN	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	O
Low	Low	JJ	I-NP	O
chol/low	chol/low	NN	I-NP	O
sat	sat	NN	I-NP	O
.	.	.	O	O

fat	fat	JJ	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NN	B-NP	O
/	/	SYM	O	O
ADA	ADA	NN	B-NP	O
2100	2100	CD	I-NP	O
cals/dy	cals/dy	NN	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
2	2	CD	B-NP	O
gram	gram	NN	I-NP	O
Sodium	Sodium	NN	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Walking	Walk	VBG	B-VP	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Gregorio	Gregorio	NNP	I-NP	O
Pensis	Pensis	NNP	I-NP	O
PCP	PCP	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
570	570	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
374-9489	374-9489	CD	I-NP	O
June	June	NNP	I-NP	O
at	at	IN	B-PP	O
12	12	CD	B-NP	O
:	:	:	O	O
15	15	CD	B-NP	O
pm	pm	NN	I-NP	O
scheduled	schedule	VBN	B-VP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Lucien	Lucien	NNP	I-NP	O
Machowski	Machowski	NNP	I-NP	O
051-469-9935	051-469-9935	CD	I-NP	O
FBMH	FBMH	NNP	I-NP	O
Cardiology	Cardiology	NNP	I-NP	O
June	June	NNP	I-NP	O
at	at	IN	B-PP	O
11am	11am	CD	B-NP	O
scheduled	schedule	VBN	B-VP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Raymon	Raymon	NNP	I-NP	O
Rentar	Rentar	NNP	I-NP	O
072-561-0481	072-561-0481	CD	I-NP	O
SUOHC	SUOHC	NNP	I-NP	O
Thoracic	Thoracic	NNP	I-NP	O
Surgery	Surgery	NNP	I-NP	O
November	November	NNP	I-NP	O
at	at	IN	B-PP	O
4pm	4pm	NN	B-NP	O
scheduled	schedule	VBN	B-VP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Lyndon	Lyndon	NNP	I-NP	O
Palos	Palos	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
115	115	CD	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
879-7452	879-7452	CD	I-NP	O
PUOH	PUOH	NN	I-NP	O
Thoracic	Thoracic	NNP	I-NP	O
Oncology	Oncology	NNP	I-NP	O
November	November	NNP	I-NP	O
at	at	IN	B-PP	O
3pm	3pm	NN	B-NP	O
scheduled	schedule	VBN	B-VP	O
,	,	,	O	O
Arrange	Arrange	NNP	B-NP	O
INR	INR	NNP	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
on	on	IN	B-PP	O
4/29	4/29	CD	B-NP	O
with	with	IN	B-PP	O
f/u	f/u	NN	B-NP	O
INR	INR	NNP	B-NP	O
's	's	POS	B-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
every	every	DT	B-NP	O
3	3	CD	I-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

INR	INR	NN	B-NP	O
's	's	POS	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
PCP	PCP	NN	B-NP	O
Erick	Erick	NNP	I-NP	O
Rottinghous	Rottinghous	NNP	I-NP	O
ALLERGY	ALLERGY	NNP	I-NP	O
:	:	:	O	O
NKA	NKA	NN	B-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
hyperkalemia	hyperkalemia	NN	B-NP	O
,	,	,	O	O
acute	acute	JJ	B-ADJP	O
on	on	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
PRINCIPAL	PRINCIPAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
acute	acute	JJ	B-ADJP	O
on	on	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
CHF	CHF	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
congestive	congestive	JJ	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
cad	cad	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
htn	htn	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
hypertension	hypertension	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
dm	dm	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
gerd	gerd	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
gastroesophageal	gastroesophageal	JJ	I-NP	O
reflux	reflux	NN	I-NP	O
disease	disease	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
hypothyroidism	hypothyroidism	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
hypothyroidism	hypothyroidism	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
mitral	mitral	JJ	I-NP	O
regurgitation	regurgitation	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
2	2	CD	I-NP	O
-RRB-	-RRB-	SYM	I-NP	O
lung	lung	NN	I-NP	O
ca	ca	NN	I-NP	O
s/p	s/p	NN	I-NP	O
RUL	RUL	NN	I-NP	O
lobectomy	lobectomy	NN	I-NP	O
and	and	CC	O	O
RLL	RLL	NN	B-NP	O
wedge	wedge	NN	I-NP	O
resection	resection	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
lung	lung	NN	I-NP	O
cancer	cancer	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
endometrial	endometrial	JJ	I-NP	O
ca	ca	NN	I-NP	O
s/p	s/p	NN	I-NP	O
TAH/BSO	TAH/BSO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
endometrial	endometrial	JJ	I-NP	O
cancer	cancer	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
basal	basal	JJ	I-NP	O
cell	cell	NN	I-NP	O
ca	ca	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
basal	basal	JJ	I-NP	O
cell	cell	NN	I-NP	O
carcinoma	carcinoma	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
CRI	CRI	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
chronic	chronic	JJ	I-NP	O
renal	renal	JJ	I-NP	O
dysfunction	dysfunction	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
renal	renal	JJ	I-NP	O
artery	artery	NN	I-NP	O
stenosis	stenosis	NN	I-NP	O
s/p	s/p	NN	I-NP	O
L	L	NN	I-NP	O
stent	stent	JJ	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
renal	renal	JJ	I-NP	O
artery	artery	NN	I-NP	O
stenosis	stenosis	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
recurrent	recurrent	JJ	I-NP	O
flash	flash	NN	I-NP	O
pulm	pulm	NN	I-NP	O
edema	edema	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
pulmonary	pulmonary	JJ	I-NP	O
edema	edema	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
none	none	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
none	none	NN	I-NP	O
BRIEF	BRIEF	NN	I-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
***	***	SYM	B-NP	O
CC	CC	NN	I-NP	O
:	:	:	O	O
hyperkalemia	hyperkalemia	NN	B-NP	O
in	in	IN	B-PP	O
setting	setting	NN	B-NP	O
of	of	IN	B-PP	O
worsening	worsen	VBG	B-VP	O
renal	renal	JJ	B-NP	O
insufficiency	insufficiency	NN	I-NP	O
***	***	SYM	B-NP	O
HPI	HPI	NN	I-NP	O
:	:	:	O	O
Pt	Pt	NN	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
75	75	CD	I-NP	O
F	F	NN	I-NP	O
with	with	IN	B-PP	O
multiple	multiple	JJ	B-NP	O
medical	medical	JJ	I-NP	O
problems	problem	NNS	I-NP	O
including	include	VBG	B-PP	O
CAD	CAD	NN	B-NP	B-protein
s/p	s/p	NN	I-NP	I-protein
PCI	PCI	NN	I-NP	I-protein
to	to	TO	B-PP	O
OM1	OM1	NN	B-NP	B-protein
'91	'91	CD	I-NP	I-protein
,	,	,	O	O
LAD	LAD	NN	B-NP	B-protein
'97	'97	CD	I-NP	I-protein
,	,	,	O	O
LCx	LCx	NN	B-NP	B-protein
'01	'01	CD	I-NP	I-protein
,	,	,	O	O
RCA	RCA	NNP	B-NP	B-protein
'02	'02	CD	I-NP	I-protein
,	,	,	O	O
dyslipidemia	dyslipidemia	NN	B-NP	O
,	,	,	O	O
CHF	CHF	NN	B-NP	B-protein
with	with	IN	B-PP	O
an	an	DT	B-NP	O
EF	EF	NN	I-NP	O
30-35	30-35	CD	B-NP	O
%	%	NN	I-NP	O
in	in	IN	B-PP	O
9/21	9/21	CD	B-NP	O
-LRB-	-LRB-	HYPH	I-NP	O
dry	dry	JJ	I-NP	O
weight	weight	NN	I-NP	O
158lbs	158lb	NNS	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
MV	MV	NN	B-NP	B-protein
repair	repair	NN	I-NP	I-protein
8/27	8/27	CD	I-NP	I-protein
,	,	,	O	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
afib	afib	NN	B-NP	O
on	on	IN	B-PP	O
coumadin	coumadin	NN	B-NP	O
,	,	,	O	O
pericardial	pericardial	JJ	B-NP	O
effusion	effusion	NN	I-NP	O
s/p	s/p	NN	I-NP	O
window	window	NN	I-NP	O
6/10	6/10	CD	I-NP	O
,	,	,	O	O
RAS	RAS	NN	B-NP	O
s/p	s/p	NN	I-NP	O
left	leave	VBD	B-VP	O
renal	renal	JJ	B-NP	O
artery	artery	NN	I-NP	O
stent	stent	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
CRI	CRI	NN	B-NP	B-protein
with	with	IN	B-PP	O
a	a	DT	B-NP	O
baseline	baseline	NN	I-NP	O
Cr	Cr	NN	I-NP	O
1.9-2	1.9-2	CD	I-NP	O
.2	.2	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
baseline	baseline	NN	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
lives	live	VBZ	B-VP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
alert	alert	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
oriented	oriented	JJ	I-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
receives	receive	VBZ	B-VP	O
assistance	assistance	NN	B-NP	O
from	from	IN	B-PP	O
VNA	VNA	NN	B-NP	B-protein
.	.	.	O	O

1	1	CD	B-NP	O
day	day	NN	I-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
pt	pt	NN	B-NP	O
was	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
in	in	IN	B-PP	O
cardiology	cardiology	NN	B-NP	O
clinic	clinic	NN	I-NP	O
by	by	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Steven	Steven	NNP	I-NP	O
Nonemaker	Nonemaker	NNP	I-NP	O
Her	Her	NNP	I-NP	O
Cr	Cr	NNP	I-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
2.3	2.3	CD	B-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
potassium	potassium	NN	I-NP	O
5.3	5.3	CD	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
following	follow	VBG	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
pt	pt	NN	B-NP	O
.	.	.	O	O

was	be	VBD	B-VP	O
instructed	instruct	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
her	her	PRP	B-NP	O
basic	basic	JJ	I-NP	O
metabolic	metabolic	JJ	I-NP	O
panel	panel	NN	I-NP	O
rechecked	rechecke	VBD	B-VP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
Cr	Cr	NN	I-NP	B-protein
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
2.6	2.6	CD	B-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
potassium	potassium	NN	I-NP	O
5.5	5.5	CD	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
advised	advise	VBN	I-VP	O
to	to	TO	I-VP	O
present	present	VB	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
FMC	FMC	NN	I-NP	O
ED	ED	VBN	B-VP	O
for	for	IN	B-PP	O
further	further	JJ	B-NP	O
evaluation	evaluation	NN	I-NP	O
and	and	CC	I-NP	O
management	management	NN	I-NP	O
of	of	IN	B-PP	O
hyperkalemia	hyperkalemia	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
worsening	worsen	VBG	B-VP	O
renal	renal	JJ	B-NP	O
insufficiency	insufficiency	NN	I-NP	O
.	.	.	O	O

****	****	SYM	B-NP	O
PMHx	PMHx	NN	I-NP	O
:	:	:	O	O
*	*	SYM	B-NP	O
CAD	CAD	NN	I-NP	O
s/p	s/p	NN	I-NP	O
PCI	PCI	NN	I-NP	O
to	to	TO	B-PP	O
OM1	OM1	NN	B-NP	B-protein
'91	'91	CD	I-NP	I-protein
,	,	,	O	O
LAD	LAD	NN	B-NP	B-protein
'97	'97	CD	I-NP	I-protein
,	,	,	O	O
Lcx	Lcx	NN	B-NP	B-protein
'01	'01	CD	I-NP	I-protein
,	,	,	O	O
RCA	RCA	NNP	B-NP	B-protein
'02	'02	CD	I-NP	I-protein
,	,	,	O	O
OM1	OM1	NN	B-NP	O
'91	'91	CD	I-NP	O
*	*	SYM	I-NP	O
dyslipidemia	dyslipidemia	NN	I-NP	O
*	*	SYM	O	O
CHF	CHF	NN	B-NP	O
EF	EF	NN	I-NP	O
30-35	30-35	CD	B-NP	O
%	%	NN	I-NP	O
9/21	9/21	CD	B-NP	O
*	*	SYM	I-NP	O
HTN	HTN	NN	I-NP	B-protein
*	*	SYM	B-NP	O
MV	MV	NN	B-NP	O
repair	repair	NN	I-NP	O
8/27	8/27	CD	I-NP	O
*	*	SYM	I-NP	O
afib	afib	NN	I-NP	O
on	on	IN	B-PP	O
coumadin	coumadin	NN	B-NP	O
*	*	SYM	I-NP	O
NSVT	NSVT	NN	I-NP	O
*	*	SYM	B-NP	O
pericardial	pericardial	JJ	I-NP	O
effusion	effusion	NN	I-NP	O
s/p	s/p	NN	I-NP	O
pericardial	pericardial	JJ	I-NP	O
window	window	NN	I-NP	O
6/10	6/10	CD	I-NP	O
*	*	SYM	I-NP	O
RAS	RAS	NN	I-NP	O
s/p	s/p	NN	I-NP	O
L	L	NN	I-NP	O
renal	renal	JJ	I-NP	O
artery	artery	NN	I-NP	O
stent	stent	NN	I-NP	O
*	*	SYM	B-NP	O
CRI	CRI	NN	I-NP	O
baseline	baseline	NN	I-NP	O
Cr	Cr	NN	I-NP	O
1.9-2	1.9-2	CD	I-NP	O
.2	.2	NN	I-NP	O
*	*	SYM	B-NP	O
GERD	GERD	NN	I-NP	O
*	*	SYM	I-NP	O
PVD	PVD	NN	I-NP	O
s/p	s/p	NN	I-NP	O
R	R	NN	I-NP	O
5th	5th	JJ	I-NP	O
toe	toe	NN	I-NP	O
amputation	amputation	NN	I-NP	O
*	*	SYM	B-NP	O
iron	iron	NN	I-NP	O
deficiency	deficiency	NN	I-NP	O
anemia	anemia	NN	I-NP	O
*	*	SYM	B-NP	O
bronchoalveolar	bronchoalveolar	JJ	I-NP	O
lung	lung	NN	I-NP	O
cancer	cancer	NN	I-NP	O
s/p	s/p	NN	I-NP	O
RUL	RUL	NN	I-NP	O
lobectomy	lobectomy	NN	I-NP	O
and	and	CC	O	O
RLL	RLL	NN	B-NP	O
wedge	wedge	NN	I-NP	O
resection	resection	NN	I-NP	O
,	,	,	O	O
*	*	SYM	B-NP	O
uterine	uterine	JJ	I-NP	O
CA	CA	NN	I-NP	O
s/p	s/p	NN	I-NP	O
TAH/BSO	TAH/BSO	NN	I-NP	O
*	*	SYM	B-NP	O
BCC	BCC	NN	I-NP	O
L	L	NN	I-NP	O
upper	upper	JJ	I-NP	O
lip	lip	NN	I-NP	O
*	*	SYM	B-NP	O
hypothyroidism	hypothyroidism	NN	I-NP	O
*	*	SYM	I-NP	O
NIDDM	NIDDM	NN	I-NP	O
****	****	SYM	I-NP	O
HOME	HOME	NN	I-NP	O
MEDS	MEDS	NN	I-NP	O
:	:	:	O	O
torsemide	torsemide	NN	B-NP	O
60	60	CD	I-NP	O
po	po	NN	I-NP	O
bid	bid	NN	I-NP	O
,	,	,	O	O
synthroid	synthroid	NN	B-NP	O
100	100	CD	I-NP	O
,	,	,	O	O
glipizide	glipizide	NN	B-NP	O
5	5	CD	I-NP	O
bid	bid	NN	I-NP	O
,	,	,	O	O
iron	iron	NN	B-NP	O
325	325	CD	I-NP	O
bid	bid	NN	I-NP	O
,	,	,	O	O
allopurinol	allopurinol	NN	B-NP	O
100mg	100mg	CD	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
ASA	ASA	NNP	B-NP	O
325	325	CD	I-NP	O
,	,	,	O	O
ativan	ativan	IN	B-NP	O
0.5	0.5	CD	I-NP	O
bid	bid	NN	I-NP	O
prn	prn	NN	I-NP	O
,	,	,	O	O
coumadin	coumadin	NN	B-NP	O
1mg	1mg	NN	I-NP	O
po	po	NN	I-NP	O
qhs	qh	NNS	I-NP	O
,	,	,	O	O
toprol	toprol	NN	B-NP	O
xl	xl	NN	I-NP	O
100mg	100mg	CD	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
metolazone	metolazone	NN	B-NP	O
2.5	2.5	CD	I-NP	O
mg	mg	NN	I-NP	O
prn	prn	NN	I-NP	O
,	,	,	O	O
nexium	nexium	NN	B-NP	O
20mg	20mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
K	K	NN	B-NP	O
20	20	CD	I-NP	O
meq	meq	NN	I-NP	O
bid	bid	NN	I-NP	O
,	,	,	O	O
pravastatin	pravastatin	NN	B-NP	O
40mg	40mg	NN	I-NP	O
,	,	,	O	O
colace	colace	NN	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
PO	PO	NN	I-NP	O
bid	bid	NN	I-NP	O
****	****	SYM	B-NP	O
ALL	ALL	NN	I-NP	O
:	:	:	O	O
NKDA	NKDA	NN	B-NP	B-protein
****	****	SYM	I-NP	O
SOC	SOC	NN	I-NP	O
HX	HX	NN	I-NP	O
:	:	:	O	O
Married	Married	NNP	B-NP	O
.	.	.	O	O

lives	life	NNS	B-NP	O
in	in	IN	B-PP	O
Holldi	Holldi	NNP	B-NP	O
Bockpu	Bockpu	NNP	I-NP	O
Sairv	Sairv	NNP	I-NP	O
Quit	Quit	NNP	I-NP	O
smoking	smoking	NN	I-NP	O
10	10	CD	B-NP	O
yrs	yr	NNS	I-NP	O
ago	ago	RB	B-ADVP	O
.	.	.	O	O

-LRB-	-LRB-	NN	B-NP	B-protein
+	+	SYM	O	O
-RRB-	-RRB-	NN	B-NP	B-protein
60	60	CD	I-NP	I-protein
pk-yr	pk-yr	NN	I-NP	I-protein
.	.	.	O	O

No	No	DT	B-NP	O
EtOH	EtOH	NN	I-NP	B-protein
or	or	CC	I-NP	O
drugs	drug	NNS	I-NP	O
.	.	.	O	O

****	****	SYM	O	O
ADMISSION	ADMISSION	NN	B-NP	O
EXAM	EXAM	NN	I-NP	O
:	:	:	O	O
T	T	NN	B-NP	O
97.5	97.5	CD	I-NP	O
HR	HR	NN	I-NP	O
Irreg	Irreg	NN	I-NP	O
76	76	CD	B-NP	O
BP	BP	NN	I-NP	O
124/56	124/56	CD	B-NP	O
O2sat	O2sat	NN	I-NP	O
97	97	CD	B-NP	O
%	%	NN	I-NP	O
RA	RA	NN	I-NP	O
Gen	Gen	NN	I-NP	O
:	:	:	O	O
NAD	NAD	NN	B-NP	O
HEENT	HEENT	NN	I-NP	O
:	:	:	O	O
L	L	NN	B-NP	O
surgical	surgical	JJ	I-NP	O
pupil	pupil	NN	I-NP	O
.	.	.	O	O

EOMI	EOMI	LS	B-LST	B-DNA
.	.	.	O	O

MMM	MMM	NN	B-NP	O
.	.	.	O	O

OP	OP	NN	B-NP	O
clear	clear	JJ	B-ADJP	O
.	.	.	O	O

CV	CV	NN	B-NP	O
:	:	:	O	O
JVP	JVP	NN	B-NP	O
6cm	6cm	NN	I-NP	O
,	,	,	O	O
irreg	irreg	NN	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
m/r/g	m/r/g	NN	I-NP	O
Pulm	Pulm	NN	I-NP	O
:	:	:	O	O
crackles	crackle	NNS	B-NP	O
RLL	RLL	NN	I-NP	O
Abd	Abd	NN	I-NP	O
:	:	:	O	O
soft	soft	JJ	B-NP	O
,	,	,	I-NP	O
umbilical	umbilical	JJ	I-NP	O
hernia	hernia	NN	I-NP	O
,	,	,	O	O
NTND	NTND	NN	B-NP	B-protein
.	.	.	O	O

+	+	SYM	O	O
BS	BS	NN	B-NP	O
Ext	Ext	NN	I-NP	O
:	:	:	O	O
trace	trace	NN	B-NP	O
edema	edema	NN	I-NP	O
LLE	LLE	NN	I-NP	O
,	,	,	O	O
distal	distal	JJ	B-NP	O
pulses	pulse	NNS	I-NP	O
not	not	RB	B-ADJP	O
palpable	palpable	JJ	I-ADJP	O
.	.	.	O	O

extremities	extremity	NNS	B-NP	O
warm	warm	JJ	B-ADJP	O
.	.	.	O	O

soft	soft	JJ	B-NP	O
nodule	nodule	NN	I-NP	O
over	over	IN	B-PP	O
left	left	JJ	B-NP	O
shin	shin	NN	I-NP	O
likely	likely	RB	B-ADJP	O
lipoma	lipoma	NN	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
clubbing/cyanosis	clubbing/cyanosis	NN	I-NP	O
.	.	.	O	O

****	****	SYM	O	B-protein
ADMISSION	ADMISSION	NN	B-NP	I-protein
LABS	LABS	NN	I-NP	I-protein
:	:	:	O	O
Cr	Cr	NN	B-NP	O
2.7	2.7	CD	I-NP	O
,	,	,	O	O
K	K	NN	B-NP	B-cell_line
4.4	4.4	CD	I-NP	I-cell_line
,	,	,	O	O
Hct	Hct	NNP	B-NP	O
37.3	37.3	CD	I-NP	O
,	,	,	O	O
BNP	BNP	NN	B-NP	B-protein
896	896	CD	I-NP	I-protein
-LRB-	-LRB-	HYPH	B-NP	I-protein
644-781	644-781	CD	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
,	,	,	O	O
INR	INR	NN	B-NP	O
1.5	1.5	CD	I-NP	O
****	****	SYM	I-NP	O
STUDIES	STUDIES	NN	I-NP	O
:	:	:	O	O
EKG	EKG	NN	B-NP	B-protein
-	-	HYPH	O	O
afib	afib	NN	B-NP	O
90	90	CD	I-NP	O
,	,	,	O	O
LBBB	LBBB	NNP	B-NP	O
morphology	morphology	NN	I-NP	O
,	,	,	O	O
L	L	NN	B-NP	O
axis	axis	NN	I-NP	O
deviation	deviation	NN	I-NP	O
,	,	,	O	O
loss	loss	NN	B-NP	O
of	of	IN	B-PP	O
anterior	anterior	JJ	B-NP	O
forces	force	NNS	I-NP	O
inferior	inferior	JJ	B-ADJP	O
+	+	SYM	B-NP	O
precordial	precordial	JJ	I-NP	O
leads	lead	NNS	I-NP	O
,	,	,	O	O
Qtc	Qtc	NN	B-NP	B-protein
515	515	CD	I-NP	I-protein
CXR	CXR	NN	I-NP	I-protein
-	-	HYPH	B-NP	O
lobectomy	lobectomy	NN	I-NP	O
staples	staple	NNS	I-NP	O
in	in	IN	B-PP	O
RUL	RUL	NN	B-NP	O
,	,	,	O	O
ill	ill	RB	B-NP	O
defined	define	VBN	I-NP	O
R	R	NN	I-NP	O
basilar	basilar	JJ	I-NP	O
opacity	opacity	NN	I-NP	O
,	,	,	O	O
mild	mild	JJ	B-NP	O
pulm	pulm	NN	I-NP	O
edema	edema	NN	I-NP	O
vs.	vs.	IN	B-PP	O
PNA	PNA	NN	B-VP	B-protein
Renal	Renal	JJ	B-NP	I-protein
U/s	U/	NNS	I-NP	I-protein
-	-	HYPH	O	O
nl	nl	NN	B-NP	B-protein
ECHO	ECHO	NN	I-NP	I-protein
-	-	HYPH	B-NP	O
EF	EF	NN	I-NP	O
30	30	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
LVH	LVH	NN	B-NP	B-protein
,	,	,	O	O
inf/post/apical	inf/post/apical	JJ	B-NP	O
AK	AK	NN	I-NP	O
+	+	SYM	B-NP	O
HK	HK	NN	I-NP	O
of	of	IN	B-PP	O
remaining	remain	VBG	B-NP	O
walls	wall	NNS	I-NP	O
,	,	,	O	O
RV	RV	NN	B-NP	B-protein
function	function	NN	I-NP	I-protein
low	low	JJ	I-NP	I-protein
nl	nl	NN	I-NP	I-protein
,	,	,	O	O
mild	mild	JJ	B-NP	O
LAE	LAE	NN	I-NP	O
,	,	,	O	O
trace	trace	NN	B-NP	O
to	to	TO	B-PP	O
mild	mild	JJ	B-NP	O
MR	MR	NN	I-NP	B-protein
,	,	,	O	O
mild	mild	JJ	B-NP	O
TR	TR	NN	I-NP	O
****	****	SYM	O	O
HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
BY	BY	NNP	I-NP	O
SYSTEMS	SYSTEMS	NNP	I-NP	O
and	and	CC	I-NP	O
PROBLEMS	PROBLEMS	NNP	I-NP	O
:	:	:	O	O
RENAL	RENAL	NN	B-NP	O
:	:	:	O	O
*	*	SYM	B-NP	O
worsening	worsen	VBG	B-VP	O
renal	renal	JJ	B-NP	O
insufficiency	insufficiency	NN	I-NP	O
*	*	SYM	B-NP	O
Pt	Pt	NN	I-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
with	with	IN	B-PP	O
worsening	worsen	VBG	B-VP	O
renal	renal	JJ	B-NP	O
insufficiency	insufficiency	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
UA	UA	NNP	I-NP	O
was	be	VBD	B-VP	O
dirty	dirty	NN	B-NP	O
and	and	CC	O	O
urine	urine	NN	B-NP	O
culture	culture	NN	I-NP	O
was	be	VBD	B-VP	O
sent	send	VBN	I-VP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
antibiotics	antibiotic	NNS	B-NP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
afebrile	afebrile	JJ	B-ADJP	O
,	,	,	O	O
asymptomatic	asymptomatic	JJ	B-ADJP	O
,	,	,	O	O
and	and	CC	O	O
without	without	IN	B-PP	O
leukocytosis	leukocytosis	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
FeBun	FeBun	NNP	I-NP	O
was	be	VBD	B-VP	O
35.9	35.9	CD	B-NP	O
,	,	,	B-ADJP	O
not	not	RB	I-ADJP	O
consistent	consistent	JJ	I-ADJP	O
with	with	IN	B-PP	O
intravascular	intravascular	JJ	B-NP	O
depletion	depletion	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
exam	exam	NN	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
appeared	appear	VBD	B-VP	O
euvolemic	euvolemic	JJ	B-ADJP	O
.	.	.	O	O

A	A	DT	B-NP	O
repeat	repeat	NN	I-NP	O
ECHO	ECHO	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
relatively	relatively	RB	B-NP	O
unchanged	unchanged	JJ	I-NP	O
systolic	systolic	JJ	I-NP	O
function	function	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
renal	renal	JJ	I-NP	O
ultrasound	ultrasound	NN	I-NP	O
was	be	VBD	B-VP	O
within	within	IN	B-PP	O
normal	normal	JJ	B-NP	O
limits	limit	NNS	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
unclear	unclear	JJ	B-ADJP	O
what	what	WP	B-NP	O
caused	cause	VBD	B-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
vacillation	vacillation	NN	I-NP	O
in	in	IN	B-PP	O
renal	renal	JJ	B-NP	O
function	function	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
likely	likely	RB	B-ADVP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
narrow	narrow	JJ	I-NP	O
range	range	NN	I-NP	O
with	with	IN	B-PP	O
respect	respect	NN	B-NP	O
to	to	TO	B-VP	O
ideal	ideal	VB	I-VP	O
volume	volume	NN	B-NP	O
status	status	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
home	home	NN	I-NP	O
torsemide	torsemide	NN	I-NP	O
dose	dose	NN	I-NP	O
while	while	IN	B-SBAR	O
in	in	IN	B-PP	O
house	house	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
weight	weight	NN	I-NP	O
on	on	IN	B-PP	O
discharge	discharge	NN	B-NP	O
was	be	VBD	B-VP	O
72.5	72.5	CD	B-NP	O
kg	kg	NN	I-NP	O
-LRB-	-LRB-	SYM	B-NP	O
159	159	CD	B-NP	O
lbs	lb	NNS	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
very	very	RB	B-ADVP	O
close	close	RB	I-ADVP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
admission	admission	NN	I-NP	O
weight	weight	NN	I-NP	O
of	of	IN	B-PP	O
72.7	72.7	CD	B-NP	O
kg	kg	NN	I-NP	O
and	and	CC	B-PP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
designated	designate	VBN	I-NP	O
dry	dry	JJ	I-NP	O
weight	weight	NN	I-NP	O
of	of	IN	B-PP	O
159	159	CD	B-NP	O
lbs	lb	NNS	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
improved	improve	VBD	B-VP	O
on	on	IN	B-PP	O
its	its	PRP$	B-NP	O
own	own	JJ	I-NP	O
from	from	IN	B-PP	O
2.7	2.7	CD	B-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
to	to	TO	B-PP	O
1.9	1.9	CD	B-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

1.9	1.9	CD	B-NP	O
represents	represent	VBZ	B-VP	O
a	a	DT	B-NP	O
value	value	NN	I-NP	O
within	within	IN	B-PP	O
her	her	PRP$	B-NP	O
baselne	baselne	NN	I-NP	O
creatinine	creatinine	NN	I-NP	O
range	range	NN	I-NP	O
of	of	IN	B-PP	O
1.8	1.8	CD	B-NP	O
to	to	TO	B-PP	O
2.2	2.2	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
will	will	MD	B-VP	O
need	need	VB	I-VP	O
close	close	RB	B-ADVP	O
follow	follow	VB	B-VP	O
up	up	RP	B-PRT	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
renal	renal	JJ	I-NP	O
function	function	NN	I-NP	O
*	*	SYM	B-NP	O
hyperkalemia	hyperkalemia	NN	I-NP	O
*	*	SYM	I-NP	O
Pt	Pt	NN	I-NP	O
presented	present	VBD	B-VP	O
with	with	IN	B-PP	O
hyperkalemia	hyperkalemia	NN	B-NP	O
in	in	IN	B-PP	O
setting	setting	NN	B-NP	O
of	of	IN	B-PP	O
worsening	worsen	VBG	B-VP	O
renal	renal	JJ	B-NP	O
insufficiency	insufficiency	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
peak	peak	JJ	I-NP	O
creatinine	creatinine	NN	I-NP	O
was	be	VBD	B-VP	O
5.5	5.5	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
recevied	recevie	VBD	B-VP	O
kayex	kayex	NN	B-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

Subsequent	Subsequent	JJ	B-NP	O
creatinine	creatinine	NN	I-NP	O
measurements	measurement	NNS	I-NP	O
were	be	VBD	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
4	4	CD	I-NP	O
's	's	POS	B-NP	O
without	without	IN	B-PP	O
k-binding	k-binding	JJ	B-NP	O
treatment	treatment	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
one	one	CD	I-NP	O
hand	hand	NN	I-NP	O
or	or	CC	I-NP	O
K	K	NN	I-NP	O
supplementation	supplementation	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
other	other	JJ	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
.	.	.	O	O

had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
on	on	IN	B-PP	O
k	k	NN	B-NP	O
supplementation	supplementation	NN	I-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
oral	oral	JJ	I-NP	O
supplements	supplement	NNS	I-NP	O
are	be	VBP	B-VP	O
being	be	VBG	I-VP	O
held	hold	VBN	I-VP	O
on	on	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
will	will	MD	B-VP	O
need	need	VB	I-VP	O
close	close	RB	B-ADVP	O
follow	follow	VB	B-VP	O
up	up	RP	B-PRT	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
potassium	potassium	NN	I-NP	O
and	and	CC	O	O
may	may	MD	B-VP	O
need	need	VB	I-VP	O
to	to	TO	I-VP	O
resume	resume	VB	I-VP	O
supplementation	supplementation	NN	B-NP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
basis	basis	NN	I-NP	O
.	.	.	O	O

CV	CV	NN	B-NP	O
:	:	:	O	O
*	*	SYM	B-NP	O
CAD	CAD	NN	I-NP	O
s/p	s/p	NN	I-NP	O
multiple	multiple	JJ	I-NP	O
PCI	PCI	NN	I-NP	O
*	*	SYM	B-NP	O
Pt	Pt	NN	I-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
ASA	ASA	NN	B-NP	O
,	,	,	O	O
bb	bb	NN	B-NP	O
,	,	,	O	O
statin	statin	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
low	low	JJ	B-NP	O
dose	dose	NN	I-NP	O
isordil	isordil	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	B-protein
BP	BP	NN	I-NP	I-protein
will	will	MD	B-VP	O
need	need	VB	I-VP	O
close	close	JJ	B-NP	O
monitoring	monitoring	NN	I-NP	O
on	on	IN	B-PP	O
this	this	DT	B-NP	O
new	new	JJ	I-NP	O
medication	medication	NN	I-NP	O
.	.	.	O	O

*	*	SYM	O	B-protein
BP	BP	NN	B-NP	I-protein
*	*	SYM	I-NP	I-protein
Pt	Pt	NN	I-NP	I-protein
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
bb	bb	NN	B-NP	O
and	and	CC	O	O
started	start	VBN	B-VP	O
on	on	IN	B-PP	O
isordil	isordil	NN	B-NP	O
,	,	,	O	O
as	as	IN	B-PP	O
above	above	RB	I-PP	O
.	.	.	O	O

On	On	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
standing	standing	JJ	I-NP	O
SBP	SBP	NN	I-NP	O
dropped	drop	VBD	B-VP	O
to	to	TO	B-PP	O
92	92	CD	B-NP	O
from	from	IN	B-PP	O
118	118	CD	B-NP	O
sitting	sitting	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
HR	HR	NN	I-NP	B-protein
remained	remain	VBD	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
70s	70	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
asymptomatic	asymptomatic	JJ	B-ADJP	O
.	.	.	O	O

In	In	IN	B-PP	O
light	light	NN	B-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
changes	change	NNS	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
torsemide	torsemide	NN	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
PO	PO	NN	I-NP	O
bid	bid	NN	I-NP	O
,	,	,	O	O
lower	low	JJR	B-ADJP	O
than	than	IN	B-PP	O
her	her	PRP$	B-NP	O
home	home	NN	I-NP	O
dose	dose	NN	I-NP	O
and	and	CC	O	O
in-hospital	in-hospital	JJ	B-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
60	60	CD	B-NP	O
mg	mg	NN	I-NP	O
pO	pO	NN	I-NP	O
bid	bid	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
instructed	instruct	VBN	I-VP	O
not	not	RB	O	O
to	to	TO	B-VP	O
walk	walk	VB	I-VP	O
without	without	IN	B-PP	O
supervision	supervision	NN	B-NP	O
and	and	CC	O	O
to	to	TO	B-VP	O
stand	stand	VB	I-VP	O
up	up	RP	B-PRT	O
slowly	slowly	RB	B-ADVP	O
from	from	IN	B-PP	O
seated	seat	VBN	B-NP	O
position	position	NN	I-NP	O
.	.	.	O	O

*	*	SYM	O	B-protein
CHF	CHF	NN	B-NP	I-protein
*	*	SYM	O	O
Pt	Pt	NN	B-NP	O
was	be	VBD	B-VP	O
thought	think	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
clinically	clinically	RB	B-ADJP	O
euvolemic	euvolemic	JJ	I-ADJP	O
on	on	IN	B-PP	O
exam	exam	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
BNP	BNP	NN	I-NP	B-protein
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
800s	800	NNS	I-NP	B-DNA
.	.	.	O	O

Her	Her	PRP$	B-NP	O
repeat	repeat	NN	I-NP	O
ECHo	ECHo	NN	I-NP	O
showed	show	VBD	B-VP	O
an	an	DT	B-NP	O
EF	EF	NN	I-NP	B-protein
of	of	IN	B-PP	O
30	30	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
relatively	relatively	RB	B-ADJP	O
unchanged	unchanged	JJ	I-ADJP	O
from	from	IN	B-PP	O
previous	previous	JJ	B-NP	O
ECHO	ECHO	NN	I-NP	O
3/24	3/24	CD	I-NP	O
She	She	NN	I-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
home	home	NN	I-NP	O
torsemide	torsemide	NN	I-NP	O
dose	dose	NN	I-NP	O
while	while	IN	B-SBAR	O
in	in	IN	B-PP	O
house	house	NN	B-NP	O
and	and	CC	O	O
discharged	discharge	VBD	B-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
lower	low	JJR	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
torsemide	torsemide	NN	B-NP	O
as	as	IN	B-SBAR	O
described	describe	VBN	B-VP	O
above	above	RB	B-ADVP	O
.	.	.	O	O

*	*	SYM	O	O
MVR	MVR	NN	B-NP	B-protein
*	*	SYM	B-VP	O
Stable	Stable	JJ	B-ADJP	O
.	.	.	O	O

*	*	SYM	O	O
afib	afib	NN	B-NP	O
*	*	SYM	I-NP	O
Pt	Pt	NN	I-NP	O
was	be	VBD	B-VP	O
rate	rate	NN	B-NP	O
controlled	control	VBN	B-VP	O
with	with	IN	B-PP	O
bb	bb	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
INR	INR	NN	I-NP	B-protein
was	be	VBD	B-VP	O
subtherapeutic	subtherapeutic	JJ	B-ADJP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
light	light	NN	B-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
coumadin	coumadin	NN	I-NP	O
dose	dose	NN	I-NP	O
was	be	VBD	B-VP	O
increased	increase	VBN	I-VP	O
from	from	IN	B-PP	O
1	1	CD	B-NP	O
to	to	TO	B-PP	O
2	2	CD	B-NP	O
while	while	IN	B-SBAR	O
in	in	IN	B-PP	O
house	house	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
INR	INR	NN	I-NP	B-protein
rose	rise	VBD	B-VP	O
to	to	TO	B-PP	O
1.9	1.9	CD	B-NP	O
on	on	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
coumadin	coumadin	NN	I-NP	O
dose	dose	NN	I-NP	O
was	be	VBD	B-VP	O
downgraded	downgrade	VBN	I-VP	O
to	to	TO	B-PP	O
1	1	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
will	will	MD	B-VP	O
need	need	VB	I-VP	O
close	close	RB	B-ADVP	O
follow	follow	VB	B-VP	O
up	up	RP	B-PRT	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
INR	INR	NN	I-NP	B-protein
.	.	.	O	O

HEME	HEME	NN	B-NP	B-protein
:	:	:	O	O
*	*	SYM	B-NP	O
iron	iron	NN	I-NP	O
deficiency	deficiency	NN	I-NP	O
anemia	anemia	NN	I-NP	O
*	*	SYM	B-NP	O
Pt	Pt	NN	I-NP	O
.	.	.	O	O

was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
iron	iron	NN	B-NP	O
.	.	.	O	O

Colonoscopy	Colonoscopy	NNP	B-NP	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
considered	consider	VBN	I-VP	O
but	but	CC	O	O
may	may	MD	B-VP	O
not	not	RB	I-VP	O
be	be	VB	I-VP	O
indicated	indicate	VBN	I-VP	O
given	give	VBN	B-NP	O
pt	pt	NN	I-NP	O
.	.	.	O	O

's	's	POS	B-NP	O
prognosis	prognosis	NN	I-NP	O
from	from	IN	B-PP	O
known	known	JJ	B-NP	O
lung	lung	NN	I-NP	O
malignancy	malignancy	NN	I-NP	O
.	.	.	O	O

ONC	ONC	NN	B-NP	O
:	:	:	O	O
*	*	SYM	B-NP	O
lung	lung	NN	I-NP	O
CA	CA	NN	I-NP	O
*	*	SYM	B-NP	O
Pt	Pt	NN	I-NP	O
has	have	VBZ	B-VP	O
CXR	CXR	NN	B-NP	O
findings	finding	NNS	I-NP	O
likely	likely	RB	B-VP	O
related	relate	VBN	I-VP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
known	known	JJ	I-NP	O
malignancy	malignancy	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
will	will	MD	B-VP	O
f/u	f/u	VB	I-VP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
outpatient	outpatient	NN	I-NP	O
oncologist	oncologist	NN	I-NP	O
.	.	.	O	O

PULM	PULM	NN	B-NP	O
:	:	:	O	O
*	*	SYM	B-NP	O
o2	o2	NN	I-NP	O
requirement	requirement	NN	I-NP	O
*	*	SYM	B-NP	O
Pt	Pt	NN	I-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
desat	desat	VB	I-VP	O
to	to	TO	B-PP	O
87	87	CD	B-NP	O
%	%	NN	I-NP	O
while	while	IN	B-PP	O
ambulating	ambulate	VBG	B-NP	O
.	.	.	O	O

Home	Home	NN	B-NP	O
O2	O2	NN	I-NP	O
was	be	VBD	B-VP	O
arranged	arrange	VBN	I-VP	O
.	.	.	O	O

Etiology	Etiology	NN	B-NP	O
of	of	IN	B-PP	O
pt	pt	NN	B-NP	O
.	.	.	O	O

's	's	POS	B-NP	O
new	new	JJ	I-NP	O
oxygen	oxygen	NN	I-NP	O
requirement	requirement	NN	I-NP	O
likely	likely	RB	B-ADVP	O
relates	relate	VBZ	B-VP	O
to	to	TO	B-PP	O
underlying	underlie	VBG	B-VP	O
lung	lung	NN	B-NP	O
malignancy	malignancy	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
perhaps	perhaps	RB	B-ADVP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
CHF	CHF	NN	I-NP	B-protein
-	-	:	O	O
although	although	IN	B-SBAR	O
she	she	PRP	B-NP	O
appears	appear	VBZ	B-VP	O
compensated	compensate	VBN	I-VP	O
from	from	IN	B-PP	O
that	that	DT	B-NP	O
standpoint	standpoint	NN	I-NP	O
.	.	.	O	O

ENDO	ENDO	NN	B-NP	B-protein
:	:	:	O	O
*	*	SYM	B-NP	O
DM	DM	NN	I-NP	O
*	*	SYM	B-NP	O
Pt	Pt	NN	I-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
SSI	SSI	NN	B-NP	O
while	while	IN	B-SBAR	O
in	in	IN	B-PP	O
house	house	NN	B-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
home	home	NN	I-NP	O
glipizide	glipizide	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
home	home	NN	I-NP	O
levoxyl	levoxyl	NN	I-NP	O
.	.	.	O	O

RHEUM	RHEUM	NN	B-NP	O
:	:	:	O	O
*	*	SYM	B-NP	O
gout	gout	NN	I-NP	O
*	*	SYM	B-NP	O
Pt	Pt	NN	I-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
prophylactic	prophylactic	JJ	I-NP	O
allopurinol	allopurinol	NN	I-NP	O
.	.	.	O	O

PROPH	PROPH	NN	B-NP	O
:	:	:	O	O
nexium/coumadin	nexium/coumadin	NN	B-NP	O
****	****	SYM	O	O
DISCHARGE	DISCHARGE	NN	B-NP	O
STATUS	STATUS	NNS	I-NP	O
:	:	:	O	O
On	On	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
pt	pt	NN	B-NP	O
.	.	.	O	O

is	be	VBZ	B-VP	O
afebrile	afebrile	JJ	B-ADJP	O
,	,	,	O	O
P	P	NN	B-NP	B-protein
70s	70s	CD	I-NP	I-protein
SBP	SBP	NN	I-NP	I-protein
90s-110s	90s-110	NNS	I-NP	I-protein
satting	satte	VBG	B-VP	O
95	95	CD	B-NP	O
%	%	NN	I-NP	O
2L	2L	NN	I-NP	O
.	.	.	O	O

Exam	Exam	NN	B-NP	O
unchanged	unchanged	JJ	B-ADJP	O
from	from	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

hct	hct	NN	B-NP	O
31	31	CD	I-NP	O
,	,	,	O	O
Cr	Cr	NNP	B-NP	O
1.9	1.9	CD	I-NP	O
,	,	,	O	O
INR	INR	NN	B-NP	O
1.9	1.9	CD	I-NP	O
****	****	SYM	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Pt	Pt	NN	B-NP	O
is	be	VBZ	B-VP	O
being	be	VBG	I-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	B-PP	O
home	home	NN	B-NP	O
with	with	IN	B-PP	O
VNA	VNA	NN	B-NP	O
services	service	NNS	I-NP	O
ADDITIONAL	ADDITIONAL	JJ	B-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
TO	TO	NN	B-NP	O
PT	PT	NN	I-NP	O
:	:	:	O	O
-	-	HYPH	B-NP	O
You	You	PRP	B-NP	B-protein
were	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
with	with	IN	B-PP	O
worsening	worsen	VBG	B-VP	O
kidney	kidney	NN	B-NP	O
function	function	NN	I-NP	O
.	.	.	O	O

An	An	DT	B-NP	O
ultrasound	ultrasound	NN	I-NP	O
of	of	IN	B-PP	O
your	your	PRP$	B-NP	O
kidneys	kidney	NNS	I-NP	O
was	be	VBD	B-VP	O
normal	normal	JJ	B-ADJP	O
and	and	CC	O	O
your	your	PRP$	B-NP	O
kidney	kidney	NN	I-NP	O
function	function	NN	I-NP	O
improved	improve	VBD	B-VP	O
.	.	.	O	O

-	-	HYPH	O	O
During	During	IN	B-PP	O
this	this	DT	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
added	add	VBD	B-VP	O
a	a	DT	B-NP	O
new	new	JJ	I-NP	O
medication	medication	NN	I-NP	O
called	call	VBN	B-VP	O
isordil	isordil	NN	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
three	three	CD	B-NP	O
times	time	NNS	I-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
decreased	decrease	VBD	B-VP	O
your	your	PRP$	B-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
torsemide	torsemide	NN	B-NP	O
to	to	TO	B-PP	O
40	40	CD	B-NP	O
mg	mg	NN	I-NP	O
two	two	CD	B-NP	O
times	time	NNS	I-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
stopped	stop	VBD	B-VP	O
your	your	PRP$	B-NP	O
medication	medication	NN	I-NP	O
called	call	VBN	B-VP	O
potassium	potassium	NN	B-NP	O
.	.	.	O	O

You	You	PRP	B-NP	B-protein
will	will	MD	B-VP	O
have	have	VB	I-VP	O
your	your	PRP$	B-NP	O
potassium	potassium	NN	I-NP	O
levels	level	NNS	I-NP	O
checked	check	VBD	B-VP	O
and	and	CC	O	O
your	your	PRP$	B-NP	O
outpatient	outpatient	NN	I-NP	O
physicians	physician	NNS	I-NP	O
will	will	MD	B-VP	O
decide	decide	VB	I-VP	O
on	on	IN	B-PP	O
whether	whether	IN	B-SBAR	O
you	you	PRP	B-NP	O
need	need	VBP	B-VP	O
to	to	TO	I-VP	O
restart	restart	VB	I-VP	O
potassium	potassium	NN	B-NP	O
and	and	CC	B-PP	O
at	at	IN	B-PP	O
what	what	WP	B-NP	O
level	level	NN	B-NP	O
.	.	.	O	O

-	-	HYPH	O	O
We	We	PRP	B-NP	O
arranged	arrange	VBD	B-VP	O
for	for	IN	B-SBAR	O
you	you	PRP	B-NP	O
to	to	TO	B-VP	O
have	have	VB	I-VP	O
home	home	NN	B-NP	O
oxygen	oxygen	NN	I-NP	O
.	.	.	O	O

Use	Use	VB	B-VP	O
it	it	PRP	B-NP	O
while	while	IN	B-SBAR	O
sleeping	sleep	VBG	B-VP	O
and	and	CC	O	O
when	when	WRB	B-ADVP	O
you	you	PRP	B-NP	O
feel	feel	VBP	B-VP	O
short	short	RB	B-ADVP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
.	.	.	O	O

Do	Do	VBP	B-VP	O
not	not	RB	I-VP	O
smoke	smoke	VB	I-VP	O
or	or	CC	I-VP	O
cook	cook	VB	I-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
stove	stove	NN	I-NP	O
while	while	IN	B-SBAR	O
using	use	VBG	B-VP	O
oxygen	oxygen	NN	B-NP	O
.	.	.	O	O

Stay	Stay	NNP	B-NP	O
away	away	RB	B-ADVP	O
from	from	IN	B-PP	O
open	open	JJ	B-NP	O
flames	flame	NNS	I-NP	O
.	.	.	O	O

-	-	HYPH	B-NP	O
Do	Do	VBP	B-VP	O
not	not	RB	I-VP	O
stand	stand	VB	I-VP	O
up	up	RP	B-PRT	O
quickly	quickly	RB	B-ADVP	O
from	from	IN	B-PP	O
a	a	DT	B-NP	O
seated	seat	VBN	I-NP	O
position	position	NN	I-NP	O
and	and	CC	O	O
do	do	VBP	B-VP	O
not	not	RB	I-VP	O
walk	walk	VB	I-VP	O
without	without	IN	B-PP	O
supervision	supervision	NN	B-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
noticed	notice	VBD	B-VP	O
your	your	PRP$	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
is	be	VBZ	B-VP	O
lower	low	JJR	B-ADJP	O
when	when	WRB	B-ADVP	O
you	you	PRP	B-NP	O
stand	stand	VBP	B-VP	O
and	and	CC	O	O
we	we	PRP	B-NP	O
do	do	VBP	B-VP	O
not	not	RB	I-VP	O
want	want	VB	I-VP	O
you	you	PRP	B-NP	O
to	to	TO	B-VP	O
get	get	VB	I-VP	O
dizzy	dizzy	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
fall	fall	JJ	I-ADJP	O
,	,	,	O	O
especially	especially	RB	B-ADVP	O
as	as	IN	B-SBAR	O
you	you	PRP	B-NP	O
are	be	VBP	B-VP	O
on	on	IN	B-PP	O
coumadin	coumadin	NN	B-NP	O
.	.	.	O	O

Do	Do	VBP	B-VP	O
not	not	RB	I-VP	O
drive	drive	VB	I-VP	O
.	.	.	O	O

-	-	HYPH	B-NP	O
Return	Return	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
emergency	emergency	NN	I-NP	O
room	room	NN	I-NP	O
or	or	CC	O	O
call	call	VB	B-VP	O
your	your	PRP$	B-NP	O
doctor	doctor	NN	I-NP	O
if	if	IN	B-SBAR	O
you	you	PRP	B-NP	O
have	have	VBP	B-VP	O
increasing	increase	VBG	I-VP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
weight	weight	NN	B-NP	O
gain	gain	NN	I-NP	O
,	,	,	O	O
chest	chest	NN	B-NP	O
pressure	pressure	NN	I-NP	O
or	or	CC	O	O
jaw	jaw	NN	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
dizziness	dizziness	NN	B-NP	O
,	,	,	O	O
lightheadedness	lightheadedness	NN	B-NP	O
,	,	,	O	O
palpitations	palpitation	NNS	B-NP	O
,	,	,	O	O
abdominal	abdominal	JJ	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
vomiting	vomiting	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
diarrhea	diarrhea	NN	B-NP	O
.	.	.	O	O

-	-	HYPH	B-NP	O
Take	Take	NN	I-NP	O
prescription	prescription	NN	I-NP	O
for	for	IN	B-PP	O
blood	blood	NN	B-NP	O
draw	draw	NN	I-NP	O
to	to	TO	B-PP	O
HHO	HHO	NN	B-NP	B-protein
on	on	IN	B-PP	O
11/25	11/25	CD	B-NP	O
Have	Have	NNP	I-NP	O
INR	INR	NNP	I-NP	O
,	,	,	O	O
chem	chem	NN	B-NP	O
7	7	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
magnesium	magnesium	NN	B-NP	O
checked	check	VBD	B-VP	O
.	.	.	O	O

As	As	IN	B-PP	O
per	per	IN	B-PP	O
script	script	NN	B-NP	O
,	,	,	O	O
results	result	NNS	B-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
faxed	fax	VBN	I-VP	O
both	both	DT	O	O
to	to	TO	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Sterling	Sterling	NNP	I-NP	O
Guandique	Guandique	NNP	I-NP	O
fax	fax	NN	I-NP	O
404-329-6993	404-329-6993	CD	I-NP	O
and	and	CC	B-PP	O
to	to	TO	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Jospeh	Jospeh	NNP	I-NP	O
Olaya	Olaya	NNP	I-NP	O
tel	tel	NN	I-NP	O
051-469-9935	051-469-9935	CD	I-NP	O
To	To	TO	I-NP	O
VNA	VNA	NN	I-NP	O
:	:	:	O	O
-	-	HYPH	B-NP	O
monitor	monitor	NN	I-NP	O
O2	O2	NN	I-NP	O
sat	sit	VBD	B-VP	O
on	on	IN	B-PP	O
home	home	NN	B-NP	O
O2	O2	NN	I-NP	O
-	-	HYPH	B-ADVP	O
do	do	VBP	B-VP	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
and	and	CC	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
check	check	NN	I-NP	O
-	-	HYPH	O	O
check	check	NN	B-NP	O
weight	weight	NN	I-NP	O
-	-	HYPH	B-NP	O
notify	notify	JJ	I-NP	O
Dr.	Dr.	NNP	I-NP	O
Robert	Robert	NNP	I-NP	O
Avenoso	Avenoso	NNP	I-NP	O
051-469-9935	051-469-9935	CD	I-NP	O
if	if	IN	B-SBAR	O
weight	weight	NN	B-NP	O
increases	increase	VBZ	B-VP	O
or	or	CC	I-VP	O
decreases	decrease	VBZ	I-VP	O
by	by	IN	B-PP	O
2	2	CD	B-NP	O
pounds	pound	NNS	I-NP	O
in	in	IN	B-PP	O
3	3	CD	B-NP	O
days	day	NNS	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Fair	Fair	NNP	B-NP	O
TO	TO	NNP	I-NP	O
DO/PLAN	DO/PLAN	NNP	I-NP	O
:	:	:	O	O
PCP/cards	PCP/card	NNS	B-NP	O
:	:	:	O	O
-	-	HYPH	B-NP	O
Monitor	Monitor	NN	I-NP	O
creatinine	creatinine	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
.	.	.	O	O

's	's	POS	B-NP	O
creatinine	creatinine	NN	I-NP	O
improved	improve	VBD	B-VP	O
from	from	IN	B-PP	O
2.7	2.7	CD	B-NP	O
to	to	TO	B-PP	O
1.9	1.9	CD	B-NP	O
.	.	.	O	O

Baseline	Baseline	NNP	B-NP	O
1.8-2	1.8-2	CD	I-NP	O
.2	.2	NN	I-NP	O
in	in	IN	B-PP	O
past	past	NN	B-NP	O
.	.	.	O	O

FeBUN	FeBUN	NN	B-NP	B-protein
was	be	VBD	B-VP	O
35.9	35.9	CD	B-NP	O
%	%	NN	I-NP	O
and	and	CC	I-NP	O
BUN/Cr	BUN/Cr	NN	I-NP	O
ratio	ratio	NN	I-NP	O
was	be	VBD	B-VP	O
20	20	CD	B-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
continued	continue	VBD	B-VP	O
torsemide	torsemide	NN	B-NP	O
60mg	60mg	NN	I-NP	O
po	po	NN	I-NP	O
bid	bid	NN	I-NP	O
.	.	.	O	O

Renal	Renal	JJ	B-NP	O
ultrasound	ultrasound	NN	I-NP	O
was	be	VBD	B-VP	O
normal	normal	JJ	B-ADJP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

-	-	HYPH	B-NP	O
Monitor	Monitor	NN	I-NP	O
potassium	potassium	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
.	.	.	O	O

's	's	POS	B-NP	O
K	K	NN	I-NP	O
decreased	decrease	VBD	B-VP	O
from	from	IN	B-PP	O
5.5	5.5	CD	B-NP	O
to	to	TO	B-PP	O
4.1	4.1	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
require	require	VB	I-VP	O
potassium	potassium	NN	B-NP	O
supplementation	supplementation	NN	I-NP	O
while	while	IN	B-SBAR	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
outpatient	outpatient	NN	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
potassium	potassium	NN	B-NP	O
was	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
.	.	.	O	O

This	This	DT	B-NP	O
may	may	MD	B-VP	O
need	need	VB	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
restarted	restart	VBN	I-VP	O
if	if	IN	B-SBAR	O
her	her	PRP$	B-NP	O
potassium	potassium	NN	I-NP	O
decreases	decrease	VBZ	B-VP	O
below	below	IN	B-PP	O
4	4	CD	B-NP	O
.	.	.	O	O

-	-	HYPH	B-NP	O
F/u	F/u	NN	I-NP	O
official	official	JJ	I-NP	O
results	result	NNS	I-NP	O
of	of	IN	B-PP	O
urine	urine	NN	B-NP	O
culture	culture	NN	I-NP	O
,	,	,	O	O
send	send	VBP	B-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-VP	O
dirty	dirty	VB	I-VP	O
UA	UA	NNP	B-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
not	not	RB	B-VP	O
treated	treat	VBN	I-VP	O
as	as	IN	B-PP	O
afebrile	afebrile	JJ	B-NP	O
,	,	,	I-NP	O
asymptomatic	asymptomatic	JJ	I-NP	O
,	,	,	I-NP	O
nl	nl	NN	I-NP	O
wbc	wbc	NN	I-NP	O
count	count	NN	I-NP	O
.	.	.	O	O

-	-	HYPH	B-NP	O
Monitor	Monitor	NN	I-NP	O
hct	hct	NN	I-NP	O
-	-	HYPH	B-VP	O
stable	stable	JJ	B-ADJP	O
in	in	IN	B-PP	O
low	low	JJ	B-NP	O
30s	30	NNS	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
has	have	VBZ	B-VP	O
known	know	VBN	I-VP	O
iron	iron	NN	B-NP	O
deficiency	deficiency	NN	I-NP	O
anemia	anemia	NN	I-NP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
on	on	IN	B-PP	O
iron	iron	NN	B-NP	O
.	.	.	O	O

-	-	HYPH	B-NP	O
Monitor	Monitor	NN	I-NP	B-protein
INR	INR	NN	I-NP	I-protein
on	on	IN	B-PP	O
coumadin	coumadin	NN	B-NP	O
.	.	.	O	O

Goal	Goal	NNP	B-NP	O
INR	INR	NNP	I-NP	O
is	be	VBZ	B-VP	O
2-3	2-3	CD	B-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
on	on	IN	B-PP	O
1	1	CD	B-NP	O
mg	mg	NN	I-NP	O
PO	PO	NN	I-NP	O
qd	qd	NN	I-NP	O
coumadin	coumadin	NN	I-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
INR	INR	NN	I-NP	B-protein
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
was	be	VBD	B-VP	O
1.5	1.5	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
coumadin	coumadin	NN	B-NP	O
2	2	CD	I-NP	O
mg	mg	NN	I-NP	O
PO	PO	NN	I-NP	O
qd	qd	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
INR	INR	NN	I-NP	B-protein
rose	rise	VBD	B-VP	O
to	to	TO	B-PP	O
1.9	1.9	CD	B-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
again	again	RB	B-ADVP	O
on	on	IN	B-PP	O
coumadin	coumadin	NN	B-NP	O
1	1	CD	I-NP	O
mg	mg	NN	I-NP	O
PO	PO	NN	I-NP	O
qd	qd	NN	I-NP	O
.	.	.	O	O

VNA	VNA	NN	B-NP	B-protein
should	should	MD	B-VP	O
draw	draw	VB	I-VP	O
her	her	PRP$	B-NP	O
INR	INR	NN	I-NP	B-protein
on	on	IN	B-PP	O
4/29	4/29	CD	B-NP	O
and	and	CC	I-NP	O
fax	fax	NN	I-NP	O
results	result	NNS	I-NP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
PCP	PCP	NN	I-NP	B-protein
.	.	.	O	O

-	-	HYPH	B-NP	O
Monitor	Monitor	NN	I-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
on	on	IN	B-PP	O
isordil	isordil	NN	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
low	low	JJ	B-NP	O
dose	dose	NN	I-NP	O
5mg	5mg	NN	I-NP	O
po	po	NN	I-NP	O
tid	tid	NN	I-NP	O
currently	currently	RB	B-ADVP	O
.	.	.	O	O

-	-	HYPH	B-NP	O
Monitor	Monitor	NN	I-NP	B-protein
SOB	SOB	NN	I-NP	I-protein
on	on	IN	B-PP	O
home	home	NN	B-NP	O
o2	o2	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
.	.	.	O	O

desatted	desatte	VBN	B-VP	O
to	to	TO	B-PP	O
87	87	CD	B-NP	O
%	%	NN	I-NP	O
while	while	IN	B-SBAR	O
ambulating	ambulate	VBG	B-VP	O
on	on	IN	B-PP	O
RA	RA	NN	B-NP	B-protein
.	.	.	O	O

Her	Her	PRP$	B-NP	O
subjective	subjective	JJ	I-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
improves	improve	VBZ	B-VP	O
tremendously	tremendously	RB	B-ADVP	O
on	on	IN	B-PP	O
2L	2L	NN	B-NP	B-protein
.	.	.	O	O

PET	PET	NN	B-NP	O
scan	scan	NN	I-NP	O
suggests	suggest	VBZ	B-VP	O
progressive	progressive	JJ	B-NP	O
lung	lung	NN	I-NP	O
CA	CA	NN	I-NP	O
.	.	.	O	O

-	-	HYPH	B-NP	O
Patient	Patient	NN	I-NP	O
is	be	VBZ	B-VP	O
DNR/DNI	DNR/DNI	NN	B-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
healthcare	healthcare	NN	I-NP	O
proxy	proxy	NN	I-NP	O
is	be	VBZ	B-VP	O
her	her	PRP$	B-NP	O
husband	husband	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
BUETER	BUETER	NNP	B-NP	O
,	,	,	O	O
PATRICK	PATRICK	NNP	B-NP	O
D.	D.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ZT35	ZT35	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
1/8/06	1/8/06	CD	I-NP	O
@	@	HYPH	B-NP	O
12	12	CD	I-NP	O
******	******	SYM	I-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

